We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





KUKA Introduces Innovative Medical Robots for the Operating Room (OR) at MEDICA 2021

By LabMedica International staff writers
Posted on 15 Nov 2021
Print article
Image: LBR Med (Photo courtesy of KUKA AG)
Image: LBR Med (Photo courtesy of KUKA AG)
KUKA AG (Augsburg, Germany) presented new application examples for its robots in the medical technology sector at this year's MEDICA, the world's largest annual medical technology trade fair, which took place from 15-18 November in Düsseldorf, Germany. At the 2021 edition of MEDICA, more than 5,000 exhibitors from 70 countries presented their newest products and ideas. The event also drew more than 120,000 trade visitors from over 170 countries.

KUKA is a supplier of intelligent automation solutions and offers robotic solutions for the medical and healthcare sectors. Robot systems from KUKA are suitable for a wide range of applications in robotic medical technology: from diagnosis and operations to rehabilitation. At MEDICA 2021, KUKA presented innovative ideas for robot-based applications in medicine, such as the collaborative LBR Med which is perfectly suited for various tasks in the medical field, thanks to its sensitive sensor technology. From diagnostics to treatment and surgical interventions – the LBR Med stands out as a perfect assistant for diverse tasks in the field of healthcare. The sensitive seven-axis lightweight robot is flexible and easy to integrate into medical products for various medical activities. With its responsive sensors, comprehensive safety precautions, hygiene-optimized surfaces and a controller designed for direct collaboration with the human operator, it is ideally suited to applications in medical technology.

KUKA demonstrated some of the possible applications of the LBR Med with the help of a medical feature cell, for example with an ultrasound-demo and a spine application. An ultrasound probe attached to the flange was guided over the body, and KUKA demonstrated how the robot records the path and then repeats the learned path independently and with constant pressure. It also demonstrated how the robot can take a change in the surface into account and continued to follow the path with the appropriate adjustment.

Additionally, KUKA’s long-time partner BEC presented guidoo - a robot-assisted surgical assistance system. The system is based on the LBR Med and enables safe and precise tissue removal during percutaneous interventions, i.e. the insertion of needles under the skin. This relieves doctors and minimizes collateral tissue damage.

Related Links:
KUKA AG

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TORCH Infections Test
TORCH Panel
New
Centrifuge
Hematocrit Centrifuge 7511M4

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.